Antifibrotic properties of epigallocatechin-3-gallate in endometriosis

Human Reproduction

Volumn 29, Issue 8, 2014, Pages 1677-1687

  Matsuzaki, Sachiko ^a,b,c   Darcha, Claude ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CNRS   (France)

Author keywords

Endometriosis; Endometrium; Epigallocatechin 3 gallate; Fibrosis

Indexed keywords

ACETYLCYSTEINE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; EPIGALLOCATECHIN GALLATE; FIBRONECTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ACTIN; CATECHIN; COL-1 PEPTIDE, HUMAN; CTGF PROTEIN, HUMAN; GELATINASE A; PEPTIDE FRAGMENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MENSTRUAL CYCLE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; CELL MOTION; DRUG EFFECTS; FIBROSIS; METABOLISM; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; ACTINS; ADULT; ANIMALS; CATECHIN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; ENDOMETRIOSIS; FEMALE; FIBRONECTINS; FIBROSIS; HUMANS; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION;

EID: 84904368627     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu123     Document Type: Article

References (44)

1. Amado NG, Fonseca BF, Cerqueira DM, Neto VM, Abreu JG. Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer. Life Sci 2011; 89:545-554.
2. Anaf V, Simon P, El Nakadi I, Fayt I, Buxant F, Buxant F, Simonart T, Peny MO, Noel JC. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 2000;15:1744-1750.
3. Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-b signaling in fibrosis. Growth Factors 2007;29:196-202.
4. Chen L, Lee MJ, Li H, Yang CS. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos 1997;25:1045-1050.
5. Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem 2011;53:155-177.
6. Chow HH, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM, Celaya CA, Rodney SR, Hara Y, Alberts DS. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin Cancer Res 2005;11:4627-4633.
7. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-584.
8. Donà M, Dell'Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 2003;170:4335-4341.
9. Foyouzi N, Berkkanoglu M, Arici A, Kwintkiewicz J, Izquierdo D, Duleba AJ. Effects of oxidants and antioxidants on proliferation of endometrial stromal cells. Fertil Steril 2004;82(Suppl. 3):1019-1022.
10. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
11. Harada M, Kan Y, Naoki H, Fukui Y, Kageyama N, Nakai M, MikiW, Kiso Y. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (2)-epicatechin. Biosci Biotechnol Biochem 1999;63:973-977.
12. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170:1807-1816. Review.
13. Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Sci 2004;117:4619-4628.
14. Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson CM, Phillips SC, Smith SK, Tavaré S, Print CG, Charnock-Jones DS. (2008) Endometrialperitoneal interactions during endometriotic lesion establishment. Am J Pathol 2008;173:700-715.
15. Hull ML, Johan MZ, Hodge WL, Robertson SA, Ingman WV. Host-derived TGFB1 deficiency suppresses lesion development in a mouse model of endometriosis. Am J Pathol 2012;180:880-887.
16. Kada T, Kaneko K, Matsuzaki S, Matsuzaki T, Hara Y. Detection and chemical identification of natural bio-antimutagens. A case of the green tea factor. Mutat Res 1985;150:127-132.
17. Laschke MW, Schwender C, Scheuer C, Vollmar B, Menger MD. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod 2008;23:2308-2318.
18. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004;18:816-827.
19. Li Y, Jiang D, Liang J, Meltzer EB, Gray A, Miura R,Wogensen L, Yamaguchi Y, Noble PW. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med 2011;208:1459-1471.
20. Liu S,XuSW, Kennedy L, Pala D, ChenY, Eastwood M, Carter DE, BlackCM, Abraham DJ, Leask A. FAK is required for TGFbeta-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix-remodeling phenotype. Mol Biol Cell 2007;18:2169-2178.
21. Massagué J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000;19:1745-1754.
22. Matsuzaki S, Darcha C. In vitro effects of a small-molecule antagonist of the Tcf/b-catenin complex on endometrial and endometriotic cells of patients with endometriosis. PLoS One 2013a;8:e61690.
23. Matsuzaki S, Darcha C. Involvement of the Wnt/b-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis. PLoS One 2013b;8:e76808.
24. Matsuzaki S, Canis M, Darcha C, Dechelotte P, Pouly JL, Bruhat MA. Fibrogenesis in peritoneal endometriosis. A semi-quantitative analysis of type-I collagen. Gynecol Obstet Invest 1999;47:197-199.
25. Nasu K, Yuge A, Tsuno A, Narahara H. Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis. Fertil Steril 2009;92:2097-2099.
26. NgôC, Chéreau C, Nicco C,Weill B, Chapron C, Batteux F. Reactive oxygen species controls endometriosis progression. Am J Pathol 2009;175:225-234.
27. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997;68:585-596.
28. Omwandho CO, Konrad L, Halis G, Oehmke F, Tinneberg HR. Role of TGF-betas in normal human endometrium and endometriosis. Hum Reprod 2010;25:101-109.
29. Paner GP, Shen SS, Lapetino S, Venkataraman G, Barkan GA, Quek ML, Ro JY, Amin MB. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 2009;33:91-98.
30. Park G, Yoon BS, Moon JH, Kim B, Jun EK, Oh S, Kim H, Song HJ, Noh JY, Oh C et al. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway. J Invest Dermatol 2008;128:2429-2441.
31. Rahimi RA, Leof EB. TGF-beta signaling: a tale of two responses. J Cell Biochem 2007;102:593-608.
32. ReddyKB,NabhaSM, AtanaskovaN.Role ofMAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003;22:395-403.
33. Ricci AG, Olivares CN, Bilotas MA, Bastón JI, Singla JJ, Meresman GF, Baranão RI. Natural therapies assessment for the treatment of endometriosis. Hum Reprod 2013;28:178-188.
34. Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011;82:1807-1821.
35. Soares SR, Martinez-Varea A, Hidalgo-Mora JJ, Pellicer A. Pharmacologic therapies in endometriosis: a systematic review. Fertil Steril 2012;98:529-555.
36. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. J Nat Rev Mol Cell Biol 2002;3:349-363.
37. Tsuno A, Nasu K, Kawano Y, Yuge A, Li H, Abe W, Narahara H. Fasudil inhibits the proliferation and contractility and induces cell cycle arrest and apoptosis of human endometriotic stromal cells: a promising agent for the treatment of endometriosis. J Clin Endocrinol Metab 2011; 96:E1944-E1952.
38. Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril 2002;77:861-870.
39. XuH, LuiWT, ChuCY,NgPS,Wang CC, Rogers MS. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod 2009;24:608-618.
40. Xu H, Becker CM, Lui WT, Chu CY, Davis TN, Kung AL, Birsner AE, D'Amato RJ,Wai Man GC,Wang CC. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/ vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril 2011;96:1021-1028.
41. Yang CS, Lambert JD, Hou Z, Ju J, Lu G, Hao X. Molecular targets for the cancer preventive activity of tea polyphenols. Mol Carcinog 2006; 45:431-435.
42. Yuge A, Nasu K, Matsumoto H, Nishida M, Narahara H. Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis. Hum Reprod 2007;22:938-944.
43. ZhangW, LiuHT.MAPKsignal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002;12:9-18.
44. Zuo F, Kaminski N, Eugui E, Allard J,Yakhini Z, Ben-Dor A, Lollini L, Morris D, KimY, DeLustroBet al.Gene expression analysis revealsmatrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 2002;99:6292-6297.